AI and Cancer Research ── Lymphoma ── 2026-11-13
Lymphoma: treatment, trials and AI
- Abstract
[18F] FDG PET/CT is central to lymphoma staging and treatment-response assessment, but repeated examinations increase cumulative radiation exposure, largely from the CT component. This retrospective study included 152 patients with 211 whole-body PET/CT scans and evaluated whether deep learning-denoised simulated low-dose CT can preserve diagnostic performance. A single-scan cohort of 108 patients was used exclusively for model development, while an independent follow-up cohort of 44 patients (103 examinations) was reserved for quantitative evaluation and a fully crossed multi-reader, multi-case study. Simulated low-dose CT images ranging from 2/3 to 1/8 of the standard dose were reviewed, and the 1/4-dose level was selected as the lowest clinically acceptable level. A denoising model was trained using paired standard-dose CT (SDCT) and simulated low-dose CT at 1/4 of the standard dose (SLDCT) images. Six nuclear medicine physicians evaluated three imaging conditions: PET/CT with SDCT, PET/CT with SLDCT, and PET/CT with denoised SLDCT (D-SLDCT), for image quality, lesion detectability, staging, and treatment response. D-SLDCT significantly improved quantitative image quality compared with SLDCT (all p 2 and among junior readers. Lesion detectability and treatment-response assessment did not differ significantly across conditions, while within-reader lesion-detection agreement with the SDCT condition improved after denoising (κ = 0.72 vs 0.67). The D-SLDCT condition preserved diagnostic performance, supporting radiation-conscious lymphoma PET/CT. This study was registered with the Chinese Clinical Trial Registry (ChiCTR) on February 14, 2026 (registration number: ChiCTR2600119037).
Journal IF-equivalent: 3.9 (OpenAlex 2-year mean citedness, value as of 2026-10-13, retrieved 2026-10-15; not the official Clarivate IF)Reference: He Y, Peng H, Li Z, Zou W, Xiang F, Li Y, et al. Feasibility of Simulated Low-Dose CT with Deep Learning Denoising for Lymphoma PET/CT Imaging: A Clinical Study on Lesion Detection, Staging, and Therapy Response. J Digit Imaging Inform med. 2026 Nov 9 [Epub ahead of print]. doi:10.1007/s10278-026-02474-1.Checked: Abstract only